Posted on 6/5/19
Lannett: Industry-Wide Drug Pricing Case Enters The Criminal Phase
SummaryOn Friday, May 31st Heritage Pharma and the Department of Justice (DOJ) released a settlement regarding the charge that Heritage had price fixed Glyburide.Specifically: Heritage Pharmaceuticals . . .
Posted on 5/16/19
Lannett: BOD Sponsored Internal Investigation Looks Like A Whitewash
SummaryOn November 4th, 2016 the CEO of LCI (Arthur Bedrosian) stated that the Board of Directors had mandated an internal investigation into allegations of price fixing.The . . .
Posted on 3/26/19
Lannett: Ding, Dong, Levo's Gone
SummaryAs reported by the company March 23rd, 2019 was officially the last day of their relationship with Levothyroxine (levo).Although Amneal had already paid the company $50m . . .
Philadelphia
